Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Guidance & Regulations

Guidance & Regulations

                        


                        Guidance for Industry
          Policies & Procedures Manual Home
          Animal & Veterinary
          Guidance & Regulations
          Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA)Guidance & Regulations Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA)
  
  	
    Share
    Post
    Linkedin

    Email
    PrintExtralabel Use of FDA Approved Drugs in AnimalsLimitations to Extralabel Use Provisions of AMDUCAExtralabel Use in Food-Producing AnimalsLabeling of Drugs Prescribed for Extralabel UseProhibitions Under AMDUCACompounding Under AMDUCAAdditional Information

The Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) permits veterinarians to prescribe extralabel uses of certain approved new animal drugs and approved human drugs for animals under certain conditions. Extralabel use refers to the use of an approved drug in a manner that is not in accordance with the approved label directions. Under AMDUCA and its implementing regulations published at Title 21, Code of Federal Regulations, Part 530 (21 CFR 530), any extralabel use of an approved new animal or human drug must be by or on the lawful order of a veterinarian within the context of a veterinarian-client-patient relationship (VCPR). Extralabel use must also comply with other provisions of 21 CFR 530. A list of drugs specifically prohibited from extralabel use appears in 21 CFR 530.41.

Extralabel Use of FDA Approved Drugs in Animals

"Extralabel use" is defined as:

*"Actual use or intended use of a drug in an animal in a manner that is not in accordance with the approved labeling. This includes, but is not limited to, use in species not listed in the labeling, use for indications (disease and other conditions) not listed in the labeling, use at dosage levels, frequencies, or routes of administration other than those stated in the labeling, and deviation from labeled withdrawal time based on these different uses." (21 CFR 530.3(a))*

Under the provisions of 21 CFR 530, the FDA recognizes the professional judgment of veterinarians, and permits the extralabel use of drugs by veterinarians under certain conditions. Extralabel use of drugs may only take place within the scope of a valid VCPR. In the absence of a valid VCPR, if an approved new animal drug is used for a use for which it is not labeled, such use has caused the drug to be deemed unsafe under the Federal Food, Drug and Cosmetic Act (“the Act”) (21 U.S.C. 360b), and therefore adulterated under the Act (21 U.S.C. 351(a)(5)).

An approved animal drug or approved human drug intended to be used for an extralabel use in an animal, other than a use in or on animal feed, is not unsafe under the Act (21 U.S.C. 360b) and is exempt from the labeling requirements under the Act (21 U.S.C. 502(f)), if such use is by or on the lawful written or oral order of a licensed veterinarian within the context of a valid VCPR and such use complies with the extralabel use regulation (21 CFR 530). Extralabel use is limited to circumstances when the health of an animal is threatened, or suffering or death may result from failure to treat. This means that extralabel use to enhance production is not permitted.

Back to the top

Limitations to Extralabel Use Provisions of AMDUCA

In addition to uses which do not comply with the conditions for permitted extralabel use set forth in 21 CFR 530, the following specific extralabel uses included in 21 CFR 530.11 are not permitted and result in the drug being deemed unsafe within the meaning of section 512 of the Act (21 U.S.C. 360b):

Extralabel use in an animal of an approved new animal drug or human drug by a lay person (except when under the supervision of a licensed veterinarian);
	Extralabel use of an approved new animal drug or human drug in or on an animal feed;
	Extralabel use resulting in any residue which may present a risk to the public health; and
	Extralabel use resulting in any residue above an established safe level, safe concentration, or tolerance.Back to the top

Extralabel Use in Food-Producing Animals

There are additional specific conditions that must be met for extralabel use of approved animal and approved human drugs in food-producing animals. The following conditions appear in 21 CFR 530.20:

There is no approved animal drug that is labeled for such use and that contains the same active ingredient in the required dosage form and concentration, except where a veterinarian finds, within the context of a valid VCPR, that the approved animal drug is clinically ineffective for its intended use.
	Before prescribing or dispensing an approved animal drug or approved human drug for an extralabel use in food animals, the veterinarian must:
	Make a careful diagnosis and evaluation of the conditions for which the drug is to be used;
		Establish a substantially extended withdrawal period prior to marketing of milk, meat, eggs, or other edible products supported by appropriate scientific information, if applicable;
		Institute procedures to assure that the identity of the treated animal or animals is carefully maintained; and
		Take appropriate measures to assure that assigned time frames for withdrawal are met and no illegal drug residues occur in any food producing animal subjected to extra-label treatment.The following additional conditions must be met for a permitted extralabel use, in food producing animals, of an approved human drug, or of an animal drug approved only for use in animals not intended for human consumption:

Such use must be accomplished in accordance with an appropriate medical rationale; and
	If scientific information on the human food safety aspect of the use of the drug in food producing animals is not available, the veterinarian must take appropriate measures to assure that the animal and its food products will not enter the human food supply.Extralabel use of an approved human drug in a food producing animal is not permitted if an animal drug approved for use in food producing animals can be used in an extralabel manner for the particular use.

Back to the top

Labeling of Drugs Prescribed for Extralabel Use

Any drug prescribed and dispensed for extralabel use by a veterinarian or dispensed by a pharmacist on the order of a veterinarian must bear or be accompanied by labeling information adequate to assure the safe and proper use of the drug. (21 CFR 530.12) At a minimum, such information shall include the following:

The name and address of the prescribing veterinarian. If the drug is dispensed by a pharmacy on the order of a veterinarian, the labeling shall include the name of the prescribing veterinarian and the name and address of the dispensing pharmacy, and may include the address of the prescribing veterinarian.
	The established name of the drug (active ingredient), or, if formulated from more than one active ingredient, the established name of each ingredient.
	Any directions for use specified by the veterinarian (including class/species or identification of the animal(s) being treated; dosage, frequency, and route of administration; and the duration of therapy).
	Any cautionary statements; and
	The veterinarian's specified withdrawal, withholding, or discard time(s) for meat, milk, eggs, or any food which might be derived from the treated animal(s).Back to the top

Prohibitions Under AMDUCA

Under the AMDUCA provisions, FDA has the right to prohibit extralabel uses of certain drugs in animals.

FDA may prohibit the extralabel use of an approved animal drug or approved human drug or class of drugs in food-producing animals if FDA determines that:

An acceptable analytical method needs to be established and such method has not been established or cannot be established; or
	The extralabel use of the drug or class of drugs presents a risk to the public health.A prohibition may be a general ban on the extralabel use of the drug or class of drugs or may be limited to a specific species, indication, dosage form, route of administration, or combination of factors. 21 CFR 530.21

FDA may prohibit the extra-label use of an animal or human drug in nonfood-producing animals if FDA determines that such extra-label use presents a risk to the public health. 21 CFR 530.30

A list of drugs, families of drugs, and substances prohibited for extra-label use in animals appears in 21 CFR 530.41.

Back to the top

Compounding Under AMDUCA

21 CFR 530.13 provides specific conditions under which extralabel use from compounding of approved animal drugs or approved human drugs is permitted. The compounding must be in compliance with all relevant provisions of 21 CFR 530. The extralabel drug use regulation does not permit animal drug compounding from active pharmaceutical ingredients (bulk drugs).

Back to the top

Additional Information

Animal Medicinal Drug Use Clarification Act (AMDUCA) of 1994
	21 CFR 530.41 - Drugs prohibited for extralabel use in animals
	Extralabel Use and AntimicrobialsBack to the top

                                                                                  Content current as of:
      04/14/2023Guidance & Regulations

          
                        


                        Guidance for Industry
          Policies & Procedures Manual
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop